Is anyone paying any attention to the finances for BTI?

On Frb 28, 2022 had cash in the amt of ~$1.73 Mil.

On May 31, 2022, their cash position was ~$750K

They spent ~$1 Mil in the 3 months. At this rate, their cash position at this time is next to nil. 

Has there been any talk on what will fund the Cresence’s, Phase 2 clinical stage-ready molecule?

Volume today was zero!

Public ownership of BTI is 97%. No major insiders to give a helping hand.

Am I missing something, narmac?

Koo